Revista nr. 53-54 - Pompiliu Manea

hémorragique qui en dérive. L’infection, bien que avec une incidence réduite persiste toujours.La vitesse de rotation doit être ajustée pour permettre le lavage de la valve aortique, empêchantla sténose et la thrombose péri-valvulaire.Néanmoins, les études montrent que les turbines axiales assurent un supporthémodynamique efficace pendant des périodes de plus que 6 mois, avec un état fonctionnelamélioré, un taux de complications réduit et une qualité de vie améliorée (31).BIBLIOGRAPHIE[1]. Zierer A, Spencer J. Melby et al. Late-Onset Driveline Infections: The Achilles’Heel of Prolonged Left Ventricular Assist Device Support. Ann. Thorac. Surg.,August 2007; 84: 515 - 520.[2]. Denton A. Cooley. Initial Clinical Experience With the Jarvik 2000 ImplantableAxial-Flow Left Ventricular Assist System. Circulation 2002 105: 2808 – 2809[3]. Mancini D. , Burkhoff D. Mechanical Device–Based Methods of Managing andTreating Heart Failure.Circulation 2005 112: 438 - 448[4]. Frazier OH, Myers JT et al. Research and Development of an Implantable, AxialFlow Left Ventricular Assist Device: the Jarvik 2000. Ann Thorac Surg2001;71:125-132[5]. Young J.B. Healing the Heart with Ventricular Assist Device Therapy:Mechanisms of Cardiac Recovery. Ann Thor Surg 2001:71:s210-9[6]. Dandel M., Weng Y. et al. LongTerm Results in Patients with Idiopathic DilatedCardiomyopathy after Weaning from Left Ventricular Assist Device. Circulation2005;112;37-45[7]. Mann DL., Willerson JT. Left Ventricular Assist Device in the Failing Heart: aBridge to Recovery, a Permanent Assist Device or a Bridge too far, Circulation1998;98/2367-9[8]. Liden H, Karason K, The Feasibility of Left Ventricular Mechanical Support as aBridge to Cardiac Recovery .European Journal of Heart Failure 2007 9;5:525-30[9]. Walter PD., Alfred J.T. et al, Left Ventricular Assist device Performance WithLong Term Circulatory Support: Lessons From the REMATCH Trial. Ann ThoracSurg 2004; 78:2123-2130[10]. Frazier O.H., Myers T. Et al, Initial Clinical Experience with the Jarvik 2000Implantable Axial Flow Left Ventricular Assist System. Circulation2002;105:2855-2860[11]. Siegenthaler M., Martin J., et al. Implantation of the Permanent Jarvik 2000 LeftVentricular Assist Device. J Am Coll Cardiol 2002;39:1764-72[12]. Fraser C., Carberry K., et al.Preliminary Experience with the MicroMed DeBakeyPediatric Ventricular Assist Device. Semin Thorac Cardiovasc Surg Pediatr CardSurg Ann 9:109-114[13]. Goldstein JD, Worldwide Experience with the MicroMed DeBakey VentricularAssist Device as a Bridge to Transplantation. Circulation 2003;108:272-277[14]. Griffith B., Kormos R., et al. HeartMate II Left Ventricular Assist System: FromConcept to First Clinical Use Ann Thor Surg 2001;71:116-120[15]. Westaby S, Katsumata T et al, Jarvik 2000 Heart: Potential for Bridge to MyocyteRecovery Circulation 1998;98;1568-1574[16]. Malani PN, Dyke DBS, et al Nosocomial Infections in Left Ventricular AssistDevice Recipients Clinical Infection Disease 2002; 34; 1295-300[17]. Siegenthaler MP, Martin J et al, The Jarvik 2000 is Associated with LessInfections than the Heart Mate Left Ventricular Assist Device European Journal ofCardioThoracic Surgery 23 (2003) 748-75548